https://dengyuepharma.com/noticias-medicas/el-avance-manufacturero-de-china-se-globaliza/2025-10-22T07:53:33+00:00https://dengyuepharma.com/noticias-medicas/como-una-droga-innovadora-de-china-se-convierte-en-el-superheroe-de-pacientes-con-enfermedades-raras/2025-10-23T07:23:35+00:00https://dengyuepharma.com/noticias-medicas/las-diez-principales-transacciones-farmaceuticas-de-china-en-2025-escondiendo-un-mapa-del-futuro/2025-10-24T08:49:25+00:00https://dengyuepharma.com/noticias-medicas/investigacion-y-desarrollo-de-medicamentos-innovadores-de-china-liderando-la-nueva-ola-de-biomedicina-global/2025-10-27T02:44:49+00:00https://dengyuepharma.com/noticias-medicas/acelere-los-medicamentos-innovadores-en-el-extranjero-sea-el-motor-estrategico-de-su-diseno-global-y-gane-el-futuro/2025-10-27T08:56:09+00:00https://dengyuepharma.com/noticias-medicas/distribuidor-farmaceutico-de-confianza-en-hong-kong-su-experto-local-en-marketing-y-cumplimiento/2025-10-28T03:05:34+00:00https://dengyuepharma.com/uncategorized/suministro-farmaceutico-confiable-en-todo-el-mundo-el-socio-preferido-para-los-mayoristas-de-importacion-y-exportacion-en-china/2025-10-28T09:03:24+00:00https://dengyuepharma.com/noticias-medicas/mayorista-profesional-chino-de-importacion-y-exportacion-de-productos-farmaceuticos-comercio-compatible-acceso-global-su-eleccion-confiable/2025-10-30T02:16:47+00:00https://dengyuepharma.com/uncategorized/mayorista-farmaceutico-chino-profesional-el-mejor-precio-y-una-cadena-de-suministro-sin-preocupaciones-todo-en-un-solo-paso/2025-10-30T09:54:25+00:00https://dengyuepharma.com/noticias-medicas/nueva-esperanza-para-los-pacientes-una-interpretacion-en-profundidad-de-los-ultimos-avances-en-medicamentos-innovadores-de-china/2025-11-12T03:03:34+00:00https://dengyuepharma.com/noticias-medicas/cooperacion-beneficiosa-para-todos-explorando-los-mejores-socios-y-modelos-para-la-innovadora-industria-farmaceutica-de-china/2025-10-31T10:00:45+00:00https://dengyuepharma.com/noticias-medicas/el-socio-preferido-de-china-para-la-distribucion-innovadora-de-medicamentos-abrir-canales-y-maximizar-el-mercado/2025-11-01T09:16:48+00:00https://dengyuepharma.com/noticias-medicas/mayorista-lider-de-medicamentos-innovadores-en-china-su-socio-confiable-de-la-cadena-de-suministro-farmaceutico/2025-11-01T09:27:01+00:00https://dengyuepharma.com/noticias-medicas/servicios-profesionales-de-distribucion-farmaceutica-china-gama-completa-de-medicamentos-y-entrega-rapida/2025-11-03T07:22:12+00:00https://dengyuepharma.com/noticias-medicas/los-hospitales-y-las-farmacias-prefieren-socios-mayoristas-de-medicamentos-de-hong-kong-suministro-estable-y-excelente-reputacion/2025-11-04T07:25:47+00:00https://dengyuepharma.com/noticias-medicas/cooperacion-de-inversion-de-mayoristas-farmaceuticos-de-china-unase-a-la-red-nacional-de-suministro-farmaceutico/2025-11-05T09:29:48+00:00https://dengyuepharma.com/noticias-medicas/plataforma-de-cooperacion-para-la-distribucion-y-venta-mayorista-de-productos-farmaceuticos-en-china-ayudando-a-las-empresas-farmaceuticas-a-expandir-sus-mercados/2025-11-06T08:35:08+00:00https://dengyuepharma.com/noticias-medicas/es-mas-conveniente-comprar-medicamentos-en-china-explicacion-detallada-del-proceso-precios-y-recomendaciones-de-medicamentos/2025-11-07T02:02:17+00:00https://dengyuepharma.com/noticias-medicas/el-olgotrelvir-sodium-ha-sido-aprobado-para-su-comercializacion/2025-11-07T06:13:05+00:00https://dengyuepharma.com/noticias-medicas/busca-distribuidores-farmaceuticos-chinos-un-analisis-exhaustivo-de-los-recursos-del-canal-profesional/2025-11-07T10:01:41+00:00https://dengyuepharma.com/guias-medicas/como-distinguir-los-medicamentos-chinos-autenticos-de-los-falsificados/2025-11-07T09:29:29+00:00https://dengyuepharma.com/noticias-medicas/pcar-19b-ya-esta-disponible/2025-11-12T02:40:05+00:00https://dengyuepharma.com/blog/de-seguidor-a-lider-adquiriendo-los-mejores-medicamentos-chinos-innovadores-del-mundo/2025-11-12T10:01:48+00:00https://dengyuepharma.com/noticias-medicas/el-anticuerpo-monoclonal-anti-vegf-de-bio-thera-logra-un-gran-exito-en-el-ensayo-clinico-de-fase-iii/2025-11-13T08:10:43+00:00https://dengyuepharma.com/noticias-medicas/los-datos-del-ensayo-clinico-de-fase-ii-de-guang-sheng-tang-gst-hg131-son-notables/2025-11-14T09:11:03+00:00https://dengyuepharma.com/noticias-medicas/la-fda-ha-aprobado-el-primer-inhibidor-de-btk-del-mundo-los-comprimidos-de-remibrutinib/2025-11-17T03:47:17+00:00https://dengyuepharma.com/guias-medicas/guia-de-seguridad-para-la-compra-de-medicamentos-en-linea/2025-11-17T09:14:44+00:00https://dengyuepharma.com/noticias-medicas/corporacion-de-exportacion-farmaceutica-de-china-dengyuepharma/2025-11-19T08:50:40+00:00https://dengyuepharma.com/guias-medicas/por-que-elegir-medicamentos-innovadores-china/2025-11-19T08:50:25+00:00https://dengyuepharma.com/blog/tendencias-futuras-en-la-industria-de-franquicias-pcd-farmaceuticas/2025-11-20T08:57:35+00:00https://dengyuepharma.com/blog/tendencias-que-influiran-en-la-distribucion-de-medicamentos-en-2025/2025-11-21T08:06:31+00:00https://dengyuepharma.com/noticias-medicas/hympavzi-se-lanzo-el-anticuerpo-tfpi-un-nuevo-avance-en-el-tratamiento-de-la-hemofilia/2025-11-24T09:27:49+00:00https://dengyuepharma.com/noticias-medicas/inyeccion-de-zanidatamab-ziihera-aprobada-en-china-para-el-cancer-de-vias-biliares-avanzado-con-her2-positivo/2025-11-26T03:18:32+00:00https://dengyuepharma.com/noticias-medicas/ltimas-noticias/china-ha-aprobado-inpegsomatropin-injection-para-mejorar-la-eficacia-de-la-terapia-con-hormona-del-crecimiento/2025-11-25T08:53:50+00:00https://dengyuepharma.com/blog/ventajas-clave-de-asociarse-con-los-principales-mayoristas-farmaceuticos-chinos-dengyuepharma/2025-11-26T07:04:32+00:00https://dengyuepharma.com/blog/como-importar-medicamentos-de-china-guia-completa-para-compradores-farmaceuticos-globales-2025/2025-12-01T08:53:51+00:00https://dengyuepharma.com/blog/los-100-principales-exportadores-farmaceuticos-de-china-como-china-se-convirtio-en-una-potencia-farmaceutica-mundial/2025-11-28T08:29:41+00:00https://dengyuepharma.com/noticias-medicas/que-tan-fuerte-es-la-industria-farmaceutica-innovadora-de-china-china-emerge-como-una-potencia-mundial-en-innovacion-farmaceutica/2025-12-01T09:13:36+00:00https://dengyuepharma.com/noticias-medicas/distribuidor-farmaceutico-de-china-redefiniendo-el-futuro-de-la-cadena-de-suministro-de-atencion-medica/2025-12-01T09:17:20+00:00https://dengyuepharma.com/blog/que-es-un-farmaco-innovador-explorando-el-futuro-de-la-medicina/2025-12-02T07:15:11+00:00https://dengyuepharma.com/noticias-medicas/nmpa-aprueba-la-inyeccion-de-picankibart-para-su-comercializacion/2025-12-03T08:44:19+00:00https://dengyuepharma.com/noticias-medicas/los-medicamentos-innovadores-de-china-se-encuentran-en-un-momento-critico-de-la-globalizacion/2025-12-04T07:38:48+00:00https://dengyuepharma.com/noticias-medicas/nbp-butylphthalide-un-avance-en-la-neuroproteccion-para-la-isquemia/2025-12-05T09:45:16+00:00https://dengyuepharma.com/blog/el-proximo-farmaco-innovador-de-gran-exito-podria-provenir-de-china/2025-12-08T08:57:26+00:00https://dengyuepharma.com/guias-medicas/prevencion-y-control-cientifico-del-cancer-de-cuello-uterino-una-guia-completa-desde-la-prevencion-y-las-prueba-del-h-hasta-la-gestion-de-la-salud/2025-12-09T07:40:33+00:00https://dengyuepharma.com/noticias-medicas/nueva-estrella-en-la-lucha-contra-medicamento-para-la-gripe-el-avance-y-el-potencial-de-las-tabletas-de-sebaloxavir-marboxil/2025-12-10T07:48:28+00:00https://dengyuepharma.com/noticias-medicas/lanzamiento-de-las-tabletas-sph3127-un-nuevo-punto-de-referencia-para-la-innovacion-en-medicina-para-la-hipertension-en-china/2025-12-12T01:49:00+00:00https://dengyuepharma.com/noticias-medicas/la-epoc-se-puede-curar-todo-lo-que-debes-saber-sobre-la-enfermedad-pulmonar-obstructiva-cronica/2025-12-12T09:55:34+00:00https://dengyuepharma.com/noticias-medicas/el-inhibidor-de-trk-de-nueva-generacion-zurletrectinib-ha-sido-aprobado-en-china-lo-que-brinda-esperanza-a-los-pacientes-con-ntrk-fusion/2025-12-15T02:36:53+00:00https://dengyuepharma.com/noticias-medicas/el-lanzamiento-de-picankibart-ha-redefinido-las-opciones-de-tratamiento-para-la-psoriasis-en-placas/2025-12-15T08:44:04+00:00https://dengyuepharma.com/noticias-medicas/una-revolucion-en-los-medicina-para-la-gripe-se-lanzan-las-capsulas-de-pixavir-marboxil/2025-12-16T06:24:15+00:00https://dengyuepharma.com/blog/farmacos-innovadores-chinos-liderazgo-global-en-evolucion-y-su-impulso-multiple/2025-12-17T07:49:40+00:00https://dengyuepharma.com/noticias-medicas/que-hay-detras-del-pequeno-exito-de-los-medicamentos-innovadores-en-china-verificacion-del-desarrollo-farmaceutico/2025-12-18T08:59:04+00:00https://dengyuepharma.com/blog/un-nuevo-objetivo-la-molecula-il-25-de-china-esta-impulsando-el-desarrollo-del-mercado-farmaceutico-de-china-y-creando-oportunidades-globales/2025-12-19T10:07:19+00:00https://dengyuepharma.com/noticias-medicas/lanzamiento-de-culmerciclib-capsules-una-nueva-era-en-el-tratamiento-del-cancer-de-mama/2025-12-22T08:17:12+00:00https://dengyuepharma.com/noticias-medicas/apuntando-a-la-antitrombina-fitusiran-sodico-un-medicamentos-para-la-hemofilia-se-lanza-en-china/2025-12-23T08:22:10+00:00https://dengyuepharma.com/noticias-medicas/una-revolucion-en-el-nefropatia-por-iga-tratamento-como-las-terapias-dirigidas-estan-cambiando-el-destino-de-los-pacientes/2025-12-25T02:21:15+00:00https://dengyuepharma.com/blog/tratamiento-de-enfermedades-inmunitarias-sistemicas-la-terapia-de-doble-objetivo-de-telitacicept-rompe-moldes/2025-12-26T01:35:24+00:00https://dengyuepharma.com/noticias-medicas/aficamten-tablets-por-que-puede-convertirse-en-una-novedosa-seleccion-de-objetivos-para-el-tratamiento-de-la-miocardiopatia-hipertrofica-obstructiva/2025-12-26T07:57:02+00:00https://dengyuepharma.com/noticias-medicas/pimicotinib-hydrochloride-obtiene-aprobacion-en-china-un-hito-global-para-el-tratamiento-del-tumor-de-celulas-gigantes-de-la-vaina-tendinosa/2025-12-29T03:06:55+00:00https://dengyuepharma.com/blog/por-que-glumetinib-se-ha-convertido-en-un-avance-global-en-medicamentos-para-el-tratamiento-del-nsclc/2025-12-29T09:52:40+00:00https://dengyuepharma.com/blog/un-gran-avance-en-el-tratamiento-de-tumores-avanzados-las-tabletas-de-qingweishi-everolimus-han-sido-aprobadas-para-su-comercializacion-abriendo-un-nuevo-capitulo-en-el-tratamiento-dirigido/2025-12-31T02:51:38+00:00https://dengyuepharma.com/blog/saibeixin-pazopanib-un-rayo-de-esperanza-para-los-medicamentos-para-el-carcinoma-de-celulas-renales/2025-12-31T08:25:17+00:00https://dengyuepharma.com/blog/orelabrutinib-una-nueva-esperanza-en-el-tratamiento-de-la-enfermedad-proliferativa-maligna-linfocitica/2026-01-04T09:38:14+00:00https://dengyuepharma.com/blog/fruquintinib-un-inhibidor-de-vegfr-para-medicamentos-contra-el-cancer-de-recto-que-bloquea-la-angiogenesis-tumoral/2026-01-14T08:56:35+00:00https://dengyuepharma.com/blog/qinganxin-avatrombopag-un-salvador-para-el-tratamiento-medicamentos-para-la-trombocitopenia-en-la-enfermedad-hepatica-cronica/2026-01-08T01:05:16+00:00https://dengyuepharma.com/blog/el-secreto-del-tebiao-recombinant-human-thrombopoietin-por-que-es-un-revolucionario-en-el-tratamiento-de-la-trombocitopenia/2026-01-12T01:03:29+00:00https://dengyuepharma.com/blog/medicamentos-para-el-tratamiento-del-hiv-biktarvy-bictegravir-sodium-emtricitabine-and-tenofovir-alafenamide-fumarate-tabletas-como-ayudar-a-los-pacientes-con-hiv-a-liberarse-de-sus-ataduras/2026-01-12T07:19:53+00:00https://dengyuepharma.com/blog/un-nuevo-objetivo-multiples-defensas-ripretinib-abre-un-nuevo-capitulo-en-el-tratamiento-del-gist-avanzado/2026-04-17T01:53:04+00:00https://dengyuepharma.com/blog/epidaza-chidamida-inhibidor-de-hdac-el-pintor-de-genes-de-las-celulas-cancerosas/2026-01-13T08:57:00+00:00https://dengyuepharma.com/blog/mejora-de-la-seguridad-renal-de-los-medicamentos-para-la-hepatitis-b-cronica-como-protege-tenofovir-amibufenamide-la-salud-futura-de-su-higado/2026-01-20T07:35:25+00:00https://dengyuepharma.com/blog/una-revolucion-en-el-tratamiento-de-la-obesidad-y-la-diabetes-tipo-2-en-2026-como-orforglipron-y-retatrutide-revolucionaran-el-manejo-de-las-enfermedades-metabolicas/2026-01-22T02:45:25+00:00https://dengyuepharma.com/blog/analisis-de-los-11-medicamentos-innovadores-mas-vistos-a-nivel-mundial-en-2026-tendencias-clave-en-la-industria-farmaceutica/2026-01-22T02:46:14+00:00https://dengyuepharma.com/blog/navelbine-vinorelbine-tartrate-por-que-este-farmaco-antitumoral-nicho-permite-que-algunos-pacientes-con-cancer-de-pulmon-avanzado-vivan-3-anos-mas/2026-01-22T02:46:45+00:00https://dengyuepharma.com/blog/adempas-riociguat-como-activar-sgc-para-tratamiento-de-la-hipertension-pulmonar/2026-01-22T02:47:22+00:00https://dengyuepharma.com/blog/rompiendo-el-dilema-de-la-resistencia-a-los-inhibidores-de-cdk4-6-por-que-se-ha-convertido-el-abemaciclibverzenios-en-la-opcion-preferida-para-el-tratamiento-del-cancer-de-mama/2026-01-22T02:48:23+00:00https://dengyuepharma.com/blog/nuevos-avances-en-el-tratamiento-del-cancer-de-pulmon-20-nuevos-medicamentos-6-tecnologias-inmunologicas-innovadoras-atacando-con-precision-8-objetivos-clave/2026-01-22T02:49:07+00:00https://dengyuepharma.com/blog/analisis-del-mecanismo-de-accion-de-dalpiciclib-inhibidor-de-cdk4-6-como-inhibe-dalpiciclib-airuikang-las-celulas-cancerosas/2026-01-22T06:25:06+00:00https://dengyuepharma.com/blog/analisis-detallado-del-mecanismo-de-accion-de-rezvilutamide-airuien-evidencia-clinica-muestra-una-reduccion-del-54-en-el-riesgo-de-progresion-de-la-enfermedad/2026-01-23T02:54:12+00:00https://dengyuepharma.com/blog/como-pueden-los-pacientes-con-caquexia-por-cancer-ganar-peso-rapidamente-revelan-datos-clinicos-del-megestrol-acetate/2026-01-26T02:42:59+00:00https://dengyuepharma.com/blog/explicacion-detallada-del-mecanismo-de-accion-de-ixekizumab-taltz-la-via-desde-il-17a-hasta-el-bloqueo-de-la-inflamacion/2026-01-26T10:01:12+00:00https://dengyuepharma.com/blog/como-cambia-el-inhibidor-de-il-17a-secukinumab-cosentyx-las-reglas-del-manejo-de-la-inflamacion/2026-02-11T06:56:33+00:00https://dengyuepharma.com/blog/como-darzalex-faspro-hace-que-el-tratamiento-del-mieloma-multiple-sea-menos-doloroso-5-horas-de-goteo-intravenoso-frente-a-3-minutos-de-inyeccion/2026-01-28T08:16:36+00:00https://dengyuepharma.com/blog/descubriendo-el-mecanismo-del-tratamiento-con-inhibidores-de-pd-l1-para-el-cancer-de-pulmon-de-celulas-pequenas-como-activa-adebrelimab-airuili-el-sistema-inmunitario/2026-01-29T07:34:51+00:00https://dengyuepharma.com/blog/tratamiento-innovador-para-la-leucemia-con-mutacion-t315i-ponatinib-iclusig/2026-01-30T08:11:07+00:00https://dengyuepharma.com/blog/tratamiento-con-inmunoterapia-pd-1-penpulimabanniko-y-su-valor-clinico/2026-02-04T02:09:43+00:00https://dengyuepharma.com/blog/farmacos-antineoplasicos-en-los-mercados-hispanohablantes/2026-02-06T09:41:47+00:00https://dengyuepharma.com/blog/5-grandes-agentes-alquilantes-panorama-de-ventas-impulsado-por-la-poblacion-de-pacientes-y-analisis-del-mercado/2026-02-07T07:16:31+00:00https://dengyuepharma.com/blog/como-elegir-los-farmacos-de-la-familia-de-los-taxanos/2026-02-07T08:07:51+00:00https://dengyuepharma.com/blog/mercado-global-del-tratamiento-de-la-hemofilia/2026-02-10T09:03:36+00:00https://dengyuepharma.com/blog/que-medicamentos-se-utilizan-para-el-tratamiento-de-la-esclerosis-lateral-amiotrofica/2026-02-12T02:31:04+00:00https://dengyuepharma.com/blog/analisis-en-profundidad-del-mercado-mundial-de-enfermedades-hematologicas-raras-y-biologicos-en-2026/2026-02-13T06:37:58+00:00https://dengyuepharma.com/blog/distribuidores-y-proveedores-farmaceuticos-de-china-guia-de-socios-confiables-2026/2026-02-26T03:15:46+00:00https://dengyuepharma.com/blog/como-el-acceso-al-mercado-esta-redefiniendo-la-exportacion-farmaceutica-de-china-al-mundo/2026-02-27T08:25:54+00:00https://dengyuepharma.com/blog/perspectivas-futuras-de-los-mayoristas-farmaceuticos-globales-5-tendencias-clave-para-2026/2026-02-28T02:04:01+00:00https://dengyuepharma.com/blog/cuales-son-los-nuevos-farmacos-para-el-tratamiento-del-cancer-de-pulmon-no-microcitico-nsclc/2026-03-03T09:49:57+00:00https://dengyuepharma.com/blog/10-innovacion-farmaceutica-china-a-seguir-en-2026/2026-03-05T09:03:10+00:00https://dengyuepharma.com/noticias-medicas/amdokitug-injection-nmpa-approval-plaque-psoriasis/2026-03-06T09:15:06+00:00https://dengyuepharma.com/blog/15-medicamentos-innovadores-contra-el-cancer/2026-03-10T09:10:57+00:00https://dengyuepharma.com/blog/pipeline-medicamentos-innovadores-china/2026-03-13T01:56:02+00:00https://dengyuepharma.com/noticias-medicas/anticuerpo-trispecifico-ak150-inmunoterapia-cancer/2026-03-14T09:04:54+00:00https://dengyuepharma.com/blog/mecanismo-de-accion-de-los-farmacos-adc/2026-03-17T09:08:03+00:00https://dengyuepharma.com/blog/mecanismo-de-anticuerpos-biespecificos-pd1-ctla4-inmunoterapia/2026-03-18T09:30:45+00:00https://dengyuepharma.com/blog/terapia-dirigida-a-her2-mecanismo-y-farmacos/2026-03-20T09:14:26+00:00https://dengyuepharma.com/guias-medicas/compra-transfronteriza-de-medicamentos-cumplimiento-logistica/2026-03-24T08:19:27+00:00https://dengyuepharma.com/blog/plataforma-global-de-cooperacion-medica/2026-03-26T09:02:08+00:00https://dengyuepharma.com/guias-medicas/guia-adquisicion-online-medicamentos-chinos-importacion/2026-03-27T08:47:23+00:00https://dengyuepharma.com/noticias-medicas/terapia-celular-til-inmunoterapia-cancer-tratamiento/2026-04-02T02:25:51+00:00https://dengyuepharma.com/noticias-medicas/terapia-acc-nk-para-cancer-fase-2-cancer-pulmon/2026-04-02T08:48:08+00:00https://dengyuepharma.com/noticias-medicas/terapia-genica-viral-basada-en-aav-fda-avance-medicina-curativa/2026-04-03T08:46:58+00:00https://dengyuepharma.com/blog/oportunidades-de-inversion-farmaceutica-2026/2026-04-08T09:00:05+00:00https://dengyuepharma.com/noticias-medicas/nuevos-farmacos-adc-innovacion-oncologia/2026-04-10T09:03:36+00:00https://dengyuepharma.com/blog/primer-farmaco-biespecifico-dll3-cd3-analisis-mercado-global/2026-04-11T09:00:22+00:00https://dengyuepharma.com/blog/3-dianas-prioritarias-de-los-adc/2026-04-14T08:49:27+00:00https://dengyuepharma.com/blog/4-investigaciones-destacadas-cancer-pulmon-avanzado-aacr-2026/2026-04-16T08:22:20+00:00https://dengyuepharma.com/noticias-medicas/5-terapias-innovadoras-clave-enfermedades-raras-2026/2026-04-17T08:23:59+00:00https://dengyuepharma.com/noticias-medicas/terapia-sctil-pionera-a-nivel-mundial-avance-inmunoterapia-cancer/2026-04-21T08:54:59+00:00https://dengyuepharma.com/noticias-medicas/sevabertinib-inhibidor-de-tirosina-quinasa-nsclc-her2-china/2026-04-23T09:01:33+00:00https://dengyuepharma.com/blog/10-terapias-innovadoras-2026-tendencias-medicas-avanzadas/2026-04-25T08:19:30+00:00https://dengyuepharma.com/blog/terapia-celular-y-genica/2026-05-08T07:28:12+00:00https://dengyuepharma.com/blog/terapia-car-t-dirigida-a-bcma-mieloma-multiple/2026-04-30T06:49:22+00:00https://dengyuepharma.com/noticias-medicas/mutacion-egfr-exon-20-pulmon/2026-05-07T09:01:13+00:00https://dengyuepharma.com/guias-medicas/sintomas-tempranos-de-la-diabetes/2026-05-08T09:30:38+00:00https://dengyuepharma.com/blog/tratamiento-linfoma-difuso-celulas-b-grandes-recaida-refractario/2026-05-09T09:14:35+00:00https://dengyuepharma.com/guias-medicas/hospitales-oncologicos-certificados-por-jci-en-china/2026-05-12T08:34:06+00:00https://dengyuepharma.com/blog/tratamiento-contra-el-cancer-en-china/2026-05-14T07:55:06+00:00https://dengyuepharma.com/noticias-medicas/primer-car-t-para-tumores-solidos-china-cancer-gastrico/2026-05-15T07:16:41+00:00https://dengyuepharma.com/noticias-medicas/primer-anticuerpo-pd-l1-subcutaneo-del-mundo/2026-05-19T09:09:06+00:00https://dengyuepharma.com/noticias-medicas/medicamento-innovador-mejorado-de-china-bcm335-fda/2026-05-21T08:11:25+00:00https://dengyuepharma.com/noticias-medicas/tratamiento-de-la-gota/2026-05-23T09:08:18+00:00https://dengyuepharma.com/blog/proveedores-globales-de-peptidos-de-retatrutide/2026-05-26T09:33:49+00:00https://dengyuepharma.com/guias-medicas/medicamentos-de-canales-no-oficiales/2026-05-28T07:47:10+00:00https://dengyuepharma.com/blog/crisis-mundial-de-medicamentos-falsificados/2026-05-29T09:10:39+00:00https://dengyuepharma.com/noticias-medicas/anbenitamab-recibe-la-aprobacion-para-su-comercializacion-her2-positivo/2026-06-02T06:14:40+00:00https://dengyuepharma.com/guias-medicas/mejor-destino-medico-para-pacientes-internacionales/2026-06-03T03:40:30+00:00https://dengyuepharma.com/blog/por-que-la-tecnologia-medica-china-atrae-pacientes-internacionales/2026-06-04T07:40:35+00:00https://dengyuepharma.com/blog/33-nuevos-medicamentos-aprobados-mayo-2026/2026-06-05T06:44:03+00:00https://dengyuepharma.com/noticias-medicas/rocbrutinib-recibe-la-aprobacion-oficial/2026-06-11T06:04:21+00:00https://dengyuepharma.com/noticias-medicas/lanoracopan-recibe-aprobacion-para-el-tratamiento-de-la-hpn/2026-06-12T06:21:32+00:00https://dengyuepharma.com/blog/es-seguro-el-uso-off-label-de-medicamentos/2026-06-13T03:46:26+00:00https://dengyuepharma.com/noticias-medicas/conteltinib-obtiene-la-aprobacion-de-la-nmpa-para-nsclc-alk-positivo/2026-06-15T06:57:59+00:00https://dengyuepharma.com/blog/mutacion-kras-cancer-de-pancreas-asco-2026/2026-06-17T03:17:05+00:00https://dengyuepharma.com/blog/primer-medicamento-protac-del-mundo/2026-06-24T01:33:14+00:00https://dengyuepharma.com/noticias-medicas/el-primer-adc-biespecifico-del-mundo/2026-06-23T03:20:45+00:00https://dengyuepharma.com/noticias-medicas/terapia-car-t-dirigida-a-cldn18-2/2026-06-24T06:40:59+00:00https://dengyuepharma.com/noticias-medicas/primer-anticuerpo-biespecifico-contra-la-rabia/2026-06-25T06:15:45+00:00https://dengyuepharma.com/noticias-medicas/primer-medicamento-antiinfeccioso-de-la-clase-ganan-del-mundo/2026-06-27T02:59:17+00:00https://dengyuepharma.com/noticias-medicas/cancer-de-mama-con-mutacion-esr1/2026-06-30T06:30:08+00:00